Hepatitis

Recommendations on the Management of Maternal Hepatitis B, C and D Infection in Pregnancy

25 Apr, 2021 | 20:44h | UTC

Recommendations of the AGG (Task Force for Obstetrics, Section Maternal Diseases) on the Management of Maternal Hepatitis B, C and D Infection in Pregnancy – Geburtshilfe und Frauenheilkunde

 

---

RCT: Ravidasvir plus sofosbuvir are effective and well tolerated in patients with chronic HCV infection, with potential as an affordable treatment for these patients

18 Apr, 2021 | 21:19h | UTC

Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial – The Lancet Gastroenterology & Hepatology

 

Commentary on Twitter

Trial results of new affordable #hepatitisC treatment showing 97% cure rate now published in @LancetGastroHep!

Ravidasvir + sofosbuvir has the potential to provide an additional affordable, simple, and efficacious #publichealth tool to eliminate HCV.

➡️https://t.co/Oo1ZHQnyn6 pic.twitter.com/FcFntfYMSC

— Drugs for Neglected Diseases initiative (@DNDi) April 16, 2021

 

---

USPSTF recommends screening for Hepatitis B Virus infection in adolescents and adults

13 Jan, 2021 | 01:43h | UTC

Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement

Author Interview: USPSTF Recommendation: Screening for Hepatitis B Virus Infection in Adolescents and Adults

Patient Page: Screening for Hepatitis B in Nonpregnant Adolescents and Adults – JAMA

 

---